Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple microbial biomolecules – non-specific oxidative targets represent a collective group of essential cellular components in bacteria, fungi, and viruses, including membrane lipids, structural proteins, metabolic enzymes, and nucleic acids. Rather than binding to a single receptor or enzyme, oxidative antimicrobial agents exert their effect by inducing widespread chemical damage across these various structures (McDonnell & Russell, 1999). This non-specific mechanism of action is characteristic of antiseptics and disinfectants, such as hydrogen peroxide and iodine-based compounds (StatPearls, 2023). By attacking multiple vital pathways simultaneously, these agents provide broad-spectrum activity and significantly reduce the likelihood of microbes developing resistance. In a clinical context, these targets are primarily exploited for topical infection control, acne treatment, wound debridement, and sterilization of medical equipment (Bigliardi et al., 2017). The resulting oxidative stress leads to irreversible loss of microbial viability through membrane lysis, protein denaturation, and metabolic collapse.
Drugs targeting these biomolecules act as oxidizing agents that generate reactive oxygen species (ROS) or directly react with functional groups, such as thiols, in microbial proteins, lipids, and nucleic acids (McDonnell & Russell, 1999). This leads to the denaturation of essential enzymes, disruption of cell membranes through lipid peroxidation, and fragmentation of DNA or RNA, resulting in rapid, non-specific microbial death (StatPearls, 2023).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple microbial biomolecules – non-specific oxidative targets.